Akoya Biosciences Inc (AKYA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Akoya Biosciences Inc Stock (AKYA) Company Profile

Akoya Biosciences Inc

Healthcare (1173)

855.896.8401

100 CAMPUS DRIVE, MARLBOROUGH

Prossima data di guadagno

Ultimi documenti SEC

AKYA's Discussions on Twitter

Confronta AKYA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AKYA Akoya Biosciences Inc	2.29	113.50M	96.63M	-63.32M	-54.55M	-1.46
ISRG Intuitive Surgical Inc	521.96	185.91B	7.87B	2.24B	586.00M	6.22
BDX Becton Dickinson Co	226.87	65.59B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	84.89	41.99B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	228.69	33.57B	4.81B	1.11B	1.35B	7.55
WST West Pharmaceutical Services Inc	327.56	23.72B	2.88B	499.60M	321.60M	6.74

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-15	Downgrade	Craig Hallum	Buy → Hold
2024-08-06	Downgrade	BTIG Research	Buy → Neutral
2024-08-06	Downgrade	JP Morgan	Overweight → Neutral
2024-08-06	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-06-21	Iniziato	Craig Hallum	Buy
2023-12-14	Iniziato	Guggenheim	Neutral
2023-07-05	Ripresa	JP Morgan	Overweight
2023-02-02	Iniziato	UBS	Buy
2022-11-03	Iniziato	CapitalOne	Overweight
2022-10-06	Iniziato	Stephens	Overweight
2022-06-22	Iniziato	BTIG Research	Buy
2022-01-06	Ripresa	Piper Sandler	Overweight
2021-05-11	Iniziato	Canaccord Genuity	Buy
2021-05-11	Iniziato	JP Morgan	Overweight
2021-05-11	Iniziato	Morgan Stanley	Overweight
2021-05-11	Iniziato	Piper Sandler	Overweight

Mostra tutto

Akoya Biosciences Inc Borsa (AKYA) Ultime notizie

Akoya Biosciences Inc Azioni (AKYA) Dati Finanziari

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc Stock (AKYA) Company Profile

Confronta AKYA con altri titoli

Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades

Akoya Biosciences Inc Borsa (AKYA) Ultime notizie

Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Grows By 20.7% - Defense World

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Analysts - Defense World

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 20.7% in December - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Sold by HighTower Advisors LLC - Defense World

Charles Schwab Investment Management Inc. Decreases Stake in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Akoya Biosciences updates director and officer indemnification agreements By Investing.com - Investing.com Canada

Akoya Biosciences updates director and officer indemnification agreements - Investing.com India

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 18.1% in November - Defense World

Market Cool On Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Pushing Shares 29% Lower - Simply Wall St

Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Expands By 18.1% - MarketBeat

Akoya Biosciences and NeraCare Enter into an Exclusive - GlobeNewswire

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions - Marketscreener.com

Akoya Biosciences Secures Global Rights for Revolutionary Early-Stage Melanoma Test - StockTitan

Nature Methods Names Spatial Proteomics 'Method of the Year 2024'Akoya Biosciences Celebrates Industry Milestone - The Manila Times

Nature Methods Names Spatial Proteomics "Method of the Year - GlobeNewswire

Akoya's Spatial Proteomics Tech Crowned 'Method of the Year 2024' by Nature Methods - StockTitan

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Akoya Biosciences' SWOT analysis: spatial proteomics firm faces headwinds - Investing.com India

Akoya Biosciences' SWOT analysis: spatial proteomics firm faces headwinds By Investing.com - Investing.com UK

Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend - Benzinga

Piper Sandler Reiterates “Overweight” Rating for Akoya Biosciences (NASDAQ:AKYA) - Defense World

Akoya Biosciences stock target cut, rating held on recent earnings report - Investing.com Canada

Akoya Biosciences' (AKYA) Overweight Rating Reiterated at Piper Sandler - MarketBeat

Revenue Downgrade: Here's What Analysts Forecast For Akoya Biosciences, Inc. (NASDAQ:AKYA) - Simply Wall St

Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook - Yahoo Finance

Canaccord Genuity Group Issues Pessimistic Forecast for Akoya Biosciences (NASDAQ:AKYA) Stock Price - Defense World

Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Akoya Biosciences shares target cut, maintains buy rating on Q3 results - Investing.com

Craig-Hallum Downgrades Akoya Biosciences (AKYA) - MSN

Akoya stock plunges 30% on outlook as Craig-Hallum cuts to hold - MSN

Akoya stock plunges 30% on outlook as Craig-Hallum cuts to hold (NASDAQ:AKYA) - Seeking Alpha

Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $3.50 by Analysts at Canaccord Genuity Group - MarketBeat

Akoya Biosciences (NASDAQ:AKYA) Stock Rating Lowered by Craig Hallum - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2024 Earnings Call Transcript - Insider Monkey

Akoya Biosciences Shares Sink After FY24 Outlook Cut - MarketWatch

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 20.8% in October - MarketBeat

Akoya Biosciences, Inc. Revises Earnings Guidance for the Full Year 2024 - Marketscreener.com

Akoya: Q3 Earnings Snapshot - Darien Times

Akoya Biosciences Reports Q3 2024 Financial Results - TipRanks

Akoya Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Akoya Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewswire

Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Is Akoya Biosciences (NASDAQ:AKYA) Using Too Much Debt? - Simply Wall St

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Akoya Biosciences (AKYA) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Precision for Medicine to Offer Spatial Biology Solutions Incorporating the PhenoCycler®-Fusion 2.0 System and the new Phenocode™ Discovery IO60 Panel from Akoya Biosciences - PR Newswire

Akoya Biosciences Unveils a New Era in Spatial Content - GlobeNewswire

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel - Yahoo Finance

Akoya Biosciences Inc Azioni (AKYA) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a AKYA